Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
Publ. Version/Full Text Volltext
DOI
PMC
 |
Open Access Gold |
as soon as is submitted to ZB.
Is it time to abandon RHAMM/HMMR as a candidate antigen for immunotherapy of acute myeloid leukemia?
Haematologica 97, 1454-1455 (2012)
Publication type
Article: Journal article
Document type
Editorial
Keywords
RHAMM-R3 PEPTIDE VACCINATION; MYELODYSPLASTIC SYNDROME; MULTIPLE-MYELOMA; LYMPHOCYTES; CELLS
ISSN (print) / ISBN
0390-6078
e-ISSN
1592-8721
Quellenangaben
Volume: 97,
Issue: 10,
Pages: 1454-1455
Publisher
Ferrata Storti Foundation
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Molecular Immunology (IMI)